Emine Özsarı
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emine Özsarı has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Suat Konuk
Department of Chest Diseases, Faculty of Medicine, Abant İzzet Baysal University, Bolu, Türkiye
11 shared publications - Orhan Kayakıran
Department of Pulmonology, Bolu Abant İzzet Baysal University Hospital, Bolu, Türkiye
4 shared publications - Elif Açar
Division of Allergy and Clinical Immunology, Department of Chest Diseases, Erciyes University School of Medicine, Kayseri, Türkiye
3 shared publications - Muhammed Emin Demirkol
General Directorate of Public Health, Ministry of Health of the Republic of Türkiye, Ankara 06430, Türkiye
3 shared publications - Musa Kaya
ZONGULDAK DEVLET HASTANESİ
3 shared publications - Alp Özel
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Bolu Abant Izzet Baysal University, 14030 Bolu, Turkey
2 shared publications
Latest Publications
- 30 December 2025
- Published by Journal of Bionic Memory in Journal of Bionic Memory
A familiar agent in the etiology of cough in adults: Bordetella Pertussis
- 30 December 2025
- Published by Journal of Bionic Memory in Journal of Bionic Memory
A familiar agent in the etiology of cough in adults: Bordetella Pertussis
- Open Access
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 255-258
Azygos lobe retrospective evaluation
Aim: The azygos lobe is a well-known anatomical variation of the lung, formed due to the aberrant course of the azygos vein during fetal development. The incidence of the azygos lobe has been reported to be between 0.4% and 1%. This study aims to identify the prevalence of the azygos lobe in a specific patient population, classify its variations, and highlight its importance in differential diagnosis and associated pathologies. Methods: A retrospective analysis was conducted on 4,549 patients who visited our pulmonology clinic between April 2014 and November 2017. The presence of an azygos lobe was identified through radiological screening. Results: Among the 4,549 patients screened, 14 cases (0.31%) of azygos lobe were detected, comprising 10 males and four females. The azygos lobe was classified based on the course of the azygos fissure: Type A (lateral to the lung apex) in seven cases (50%), Type B (midline and more vertical) in three cases (21%), and Type C (medial, extending into the mediastinum) in four cases (29%). Additionally, 12 cases (85.7%) were located on the right side, while two cases (14.3%) were on the left. Conclusions: The azygos lobe is most commonly detected incidentally during imaging for unrelated conditions. Our study emphasizes the importance of recognizing the azygos lobe as a differential diagnosis and investigating potential coexisting pathologies. The findings contribute to existing statistical data on the prevalence and anatomical variations of the azygos lobe.
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 255-258
Open AccessAzygos lobe retrospective evaluation
Aim: The azygos lobe is a well-known anatomical variation of the lung, formed due to the aberrant course of the azygos vein during fetal development. The incidence of the azygos lobe has been reported to be between 0.4% and 1%. This study aims to identify the prevalence of the azygos lobe in a specific patient population, classify its variations, and highlight its importance in differential diagnosis and associated pathologies. Methods: A retrospective analysis was conducted on 4,549 patients who visited our pulmonology clinic between April 2014 and November 2017. The presence of an azygos lobe was identified through radiological screening. Results: Among the 4,549 patients screened, 14 cases (0.31%) of azygos lobe were detected, comprising 10 males and four females. The azygos lobe was classified based on the course of the azygos fissure: Type A (lateral to the lung apex) in seven cases (50%), Type B (midline and more vertical) in three cases (21%), and Type C (medial, extending into the mediastinum) in four cases (29%). Additionally, 12 cases (85.7%) were located on the right side, while two cases (14.3%) were on the left. Conclusions: The azygos lobe is most commonly detected incidentally during imaging for unrelated conditions. Our study emphasizes the importance of recognizing the azygos lobe as a differential diagnosis and investigating potential coexisting pathologies. The findings contribute to existing statistical data on the prevalence and anatomical variations of the azygos lobe.
- Open Access
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 255-258
Azygos lobe retrospective evaluation
Aim: The azygos lobe is a well-known anatomical variation of the lung, formed due to the aberrant course of the azygos vein during fetal development. The incidence of the azygos lobe has been reported to be between 0.4% and 1%. This study aims to identify the prevalence of the azygos lobe in a specific patient population, classify its variations, and highlight its importance in differential diagnosis and associated pathologies. Methods: A retrospective analysis was conducted on 4,549 patients who visited our pulmonology clinic between April 2014 and November 2017. The presence of an azygos lobe was identified through radiological screening. Results: Among the 4,549 patients screened, 14 cases (0.31%) of azygos lobe were detected, comprising 10 males and four females. The azygos lobe was classified based on the course of the azygos fissure: Type A (lateral to the lung apex) in seven cases (50%), Type B (midline and more vertical) in three cases (21%), and Type C (medial, extending into the mediastinum) in four cases (29%). Additionally, 12 cases (85.7%) were located on the right side, while two cases (14.3%) were on the left. Conclusions: The azygos lobe is most commonly detected incidentally during imaging for unrelated conditions. Our study emphasizes the importance of recognizing the azygos lobe as a differential diagnosis and investigating potential coexisting pathologies. The findings contribute to existing statistical data on the prevalence and anatomical variations of the azygos lobe.
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 255-258
Open AccessAzygos lobe retrospective evaluation
Aim: The azygos lobe is a well-known anatomical variation of the lung, formed due to the aberrant course of the azygos vein during fetal development. The incidence of the azygos lobe has been reported to be between 0.4% and 1%. This study aims to identify the prevalence of the azygos lobe in a specific patient population, classify its variations, and highlight its importance in differential diagnosis and associated pathologies. Methods: A retrospective analysis was conducted on 4,549 patients who visited our pulmonology clinic between April 2014 and November 2017. The presence of an azygos lobe was identified through radiological screening. Results: Among the 4,549 patients screened, 14 cases (0.31%) of azygos lobe were detected, comprising 10 males and four females. The azygos lobe was classified based on the course of the azygos fissure: Type A (lateral to the lung apex) in seven cases (50%), Type B (midline and more vertical) in three cases (21%), and Type C (medial, extending into the mediastinum) in four cases (29%). Additionally, 12 cases (85.7%) were located on the right side, while two cases (14.3%) were on the left. Conclusions: The azygos lobe is most commonly detected incidentally during imaging for unrelated conditions. Our study emphasizes the importance of recognizing the azygos lobe as a differential diagnosis and investigating potential coexisting pathologies. The findings contribute to existing statistical data on the prevalence and anatomical variations of the azygos lobe.
- Open Access
- 29 September 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2566392
Prevalence of fibromyalgia in asthma and its impact on asthma control: a case-control study
Asthma and fibromyalgia are chronic conditions that significantly impair quality of life and share common inflammatory and neurophysiological mechanisms. This study aimed to investigate the prevalence of fibromyalgia in asthma patients and examine its impact on asthma control. In this case-control study, 120 patients diagnosed with asthma and 120 age- and sex-matched healthy controls were enrolled. Fibromyalgia was diagnosed based on the 2016 revised ACR criteria using the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS). Asthma control was assessed using the Asthma Control Test (ACT). The relationship between fibromyalgia and asthma control was analyzed using independent t-tests, chi-square tests, logistic regression, and ROC analysis. The prevalence of fibromyalgia in the asthma group was 16.7% compared to 3.3% in controls (p < 0.001). Asthma patients with fibromyalgia had significantly lower ACT scores than those without (18.2 ± 2.9 vs. 20.1 ± 2.4; p = 0.004). The proportion of patients with uncontrolled asthma was higher among those with fibromyalgia (60% vs. 35%). Logistic regression showed that fibromyalgia was associated with increased odds of uncontrolled asthma (OR = 2.16), although this was not statistically significant (p = 0.103). ACT scores showed no significant correlation with WPI or SSS. ROC analysis revealed that the ACT score had no discriminatory power in identifying fibromyalgia (AUC = 0.50). Fibromyalgia is a common comorbidity in asthma patients and may adversely affect perceived asthma control. However, the ACT score alone may not be a reliable indicator of fibromyalgia presence, suggesting the need for multidimensional assessment tools in routine asthma care.
- 29 September 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2566392
Open AccessPrevalence of fibromyalgia in asthma and its impact on asthma control: a case-control study
Asthma and fibromyalgia are chronic conditions that significantly impair quality of life and share common inflammatory and neurophysiological mechanisms. This study aimed to investigate the prevalence of fibromyalgia in asthma patients and examine its impact on asthma control. In this case-control study, 120 patients diagnosed with asthma and 120 age- and sex-matched healthy controls were enrolled. Fibromyalgia was diagnosed based on the 2016 revised ACR criteria using the Widespread Pain Index (WPI) and Symptom Severity Scale (SSS). Asthma control was assessed using the Asthma Control Test (ACT). The relationship between fibromyalgia and asthma control was analyzed using independent t-tests, chi-square tests, logistic regression, and ROC analysis. The prevalence of fibromyalgia in the asthma group was 16.7% compared to 3.3% in controls (p < 0.001). Asthma patients with fibromyalgia had significantly lower ACT scores than those without (18.2 ± 2.9 vs. 20.1 ± 2.4; p = 0.004). The proportion of patients with uncontrolled asthma was higher among those with fibromyalgia (60% vs. 35%). Logistic regression showed that fibromyalgia was associated with increased odds of uncontrolled asthma (OR = 2.16), although this was not statistically significant (p = 0.103). ACT scores showed no significant correlation with WPI or SSS. ROC analysis revealed that the ACT score had no discriminatory power in identifying fibromyalgia (AUC = 0.50). Fibromyalgia is a common comorbidity in asthma patients and may adversely affect perceived asthma control. However, the ACT score alone may not be a reliable indicator of fibromyalgia presence, suggesting the need for multidimensional assessment tools in routine asthma care.
- 5 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 247, 108287
Retrospective evaluation of 5-year tuberculosis cases in Bolu, Turkey (before, during and after the COVID-19 pandemic)
- 5 August 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 247, 108287
Retrospective evaluation of 5-year tuberculosis cases in Bolu, Turkey (before, during and after the COVID-19 pandemic)
- Open Access
- 30 July 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (3) , 162-168
Evaluation of pulmonary embolism patients in a tertiary hospital with clinical, radiological and laboratory features
Objective: Pulmonary thromboembolism (PTE) presents with a wide range of symptoms, outcomes, and radiographic features. We evaluated the clinical, laboratory, and radiological features of PTE. Materials and Methods: A retrospective study was conducted on patients diagnosed with pulmonary thromboembolism (PTE) between 2019 and 2021 at the Department of Chest Diseases, Abant Izzet Baysal University Hospital. Patients with suspected acute PTE and those diagnosed with pulmonary embolism based on CT angiography were included. Patients with chronic PTE, as diagnosed by ventilation/perfusion scintigraphy, were excluded. Results: Of the 100 patients included, 42% were female and 58% were male. The mean age of the patients was 70.50 ± 13.54 years. The most common symptom was dyspnea, followed by cough and chest pain. Troponin I levels were elevated in 62 individuals. D-dimer concentrations of all patients were above the upper limit of 0.55 mg/L. Massive PTE was seen in 15% of patients, submassive PTE in 40%, and non-massive PTE in 45%. In addition, systolic pulmonary artery pressure (sPAP) was high in 67% of the cases. Patients with elevated sPAP had a higher mean age, had received more thrombolytic therapy, and had a higher rate of major and submassive pulmonary embolisms. Troponin I values were seen to be elevated in massive PTE, as expected (p=0.024). D-dimer values were significantly higher in patients with pulmonary embolism in the main branch (p=0.018). Conclusion: In light of the data we obtained from our study, we believe that a detailed cardiovascular system evaluation, including Troponin I and systolic pulmonary artery pressure measurements, is very important in the diagnosis process and in predicting the prognosis after diagnosis in patients presenting with suspected pulmonary thromboembolism.
- 30 July 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (3) , 162-168
Open AccessEvaluation of pulmonary embolism patients in a tertiary hospital with clinical, radiological and laboratory features
Objective: Pulmonary thromboembolism (PTE) presents with a wide range of symptoms, outcomes, and radiographic features. We evaluated the clinical, laboratory, and radiological features of PTE. Materials and Methods: A retrospective study was conducted on patients diagnosed with pulmonary thromboembolism (PTE) between 2019 and 2021 at the Department of Chest Diseases, Abant Izzet Baysal University Hospital. Patients with suspected acute PTE and those diagnosed with pulmonary embolism based on CT angiography were included. Patients with chronic PTE, as diagnosed by ventilation/perfusion scintigraphy, were excluded. Results: Of the 100 patients included, 42% were female and 58% were male. The mean age of the patients was 70.50 ± 13.54 years. The most common symptom was dyspnea, followed by cough and chest pain. Troponin I levels were elevated in 62 individuals. D-dimer concentrations of all patients were above the upper limit of 0.55 mg/L. Massive PTE was seen in 15% of patients, submassive PTE in 40%, and non-massive PTE in 45%. In addition, systolic pulmonary artery pressure (sPAP) was high in 67% of the cases. Patients with elevated sPAP had a higher mean age, had received more thrombolytic therapy, and had a higher rate of major and submassive pulmonary embolisms. Troponin I values were seen to be elevated in massive PTE, as expected (p=0.024). D-dimer values were significantly higher in patients with pulmonary embolism in the main branch (p=0.018). Conclusion: In light of the data we obtained from our study, we believe that a detailed cardiovascular system evaluation, including Troponin I and systolic pulmonary artery pressure measurements, is very important in the diagnosis process and in predicting the prognosis after diagnosis in patients presenting with suspected pulmonary thromboembolism.
- Open Access
- 30 July 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (3) , 162-168
Evaluation of pulmonary embolism patients in a tertiary hospital with clinical, radiological and laboratory features
Objective: Pulmonary thromboembolism (PTE) presents with a wide range of symptoms, outcomes, and radiographic features. We evaluated the clinical, laboratory, and radiological features of PTE. Materials and Methods: A retrospective study was conducted on patients diagnosed with pulmonary thromboembolism (PTE) between 2019 and 2021 at the Department of Chest Diseases, Abant Izzet Baysal University Hospital. Patients with suspected acute PTE and those diagnosed with pulmonary embolism based on CT angiography were included. Patients with chronic PTE, as diagnosed by ventilation/perfusion scintigraphy, were excluded. Results: Of the 100 patients included, 42% were female and 58% were male. The mean age of the patients was 70.50 ± 13.54 years. The most common symptom was dyspnea, followed by cough and chest pain. Troponin I levels were elevated in 62 individuals. D-dimer concentrations of all patients were above the upper limit of 0.55 mg/L. Massive PTE was seen in 15% of patients, submassive PTE in 40%, and non-massive PTE in 45%. In addition, systolic pulmonary artery pressure (sPAP) was high in 67% of the cases. Patients with elevated sPAP had a higher mean age, had received more thrombolytic therapy, and had a higher rate of major and submassive pulmonary embolisms. Troponin I values were seen to be elevated in massive PTE, as expected (p=0.024). D-dimer values were significantly higher in patients with pulmonary embolism in the main branch (p=0.018). Conclusion: In light of the data we obtained from our study, we believe that a detailed cardiovascular system evaluation, including Troponin I and systolic pulmonary artery pressure measurements, is very important in the diagnosis process and in predicting the prognosis after diagnosis in patients presenting with suspected pulmonary thromboembolism.
- 30 July 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (3) , 162-168
Open AccessEvaluation of pulmonary embolism patients in a tertiary hospital with clinical, radiological and laboratory features
Objective: Pulmonary thromboembolism (PTE) presents with a wide range of symptoms, outcomes, and radiographic features. We evaluated the clinical, laboratory, and radiological features of PTE. Materials and Methods: A retrospective study was conducted on patients diagnosed with pulmonary thromboembolism (PTE) between 2019 and 2021 at the Department of Chest Diseases, Abant Izzet Baysal University Hospital. Patients with suspected acute PTE and those diagnosed with pulmonary embolism based on CT angiography were included. Patients with chronic PTE, as diagnosed by ventilation/perfusion scintigraphy, were excluded. Results: Of the 100 patients included, 42% were female and 58% were male. The mean age of the patients was 70.50 ± 13.54 years. The most common symptom was dyspnea, followed by cough and chest pain. Troponin I levels were elevated in 62 individuals. D-dimer concentrations of all patients were above the upper limit of 0.55 mg/L. Massive PTE was seen in 15% of patients, submassive PTE in 40%, and non-massive PTE in 45%. In addition, systolic pulmonary artery pressure (sPAP) was high in 67% of the cases. Patients with elevated sPAP had a higher mean age, had received more thrombolytic therapy, and had a higher rate of major and submassive pulmonary embolisms. Troponin I values were seen to be elevated in massive PTE, as expected (p=0.024). D-dimer values were significantly higher in patients with pulmonary embolism in the main branch (p=0.018). Conclusion: In light of the data we obtained from our study, we believe that a detailed cardiovascular system evaluation, including Troponin I and systolic pulmonary artery pressure measurements, is very important in the diagnosis process and in predicting the prognosis after diagnosis in patients presenting with suspected pulmonary thromboembolism.
- Open Access
- 12 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1909
The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity
Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274–0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365–0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.
- 12 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (6) , 1909
Open AccessThe Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity
Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274–0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365–0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 839-844
Retrospective evaluation of 92 cases on the diagnosis and treatment of interstitial lung diseases
Aim Interstitial lung diseases (ILDs) constitute a group of over 200 diseases affecting gas exchange, characterized by inflammation and fibroproliferation. The approach of a tertiary hospital to this heterogeneous group of diseases, which is challenging to manage, was reviewed to explore important features for diagnosis and treatment. Methods Ninety-two patients evaluated for ILD at the Department of Chest Diseases, Abant Izzet Baysal University Faculty of Medicine, between January 1, 2018, and 2019, were examined in terms of demographic characteristics, clinical findings, pulmonary function tests, radiological images, diagnostic methods, and treatment modalities. Results A total of 92 patients, with a mean age of 62.23 ± 11.78- years (range: 32-88), including 69 males, were evaluated. The most common presenting complaints among symptomatic patients (92.4%) were dyspnea (77.6%) and cough (64.7%). Following clinical, radiological, and pathological evaluations, various ILDs were identified, predominantly idiopathic pulmonary fibrosis (25%), followed by nonspecific interstitial pneumonia (15.2%), pneumoconiosis (15.2%), sarcoidosis, hypersensitivity pneumonitis, drug-induced lung diseases, collagen vascular diseases, Langerhans cell histiocytosis, respiratory bronchiolitis- associated ILD, lymphocytic interstitial pneumonia, and cryptogenic organizing pneumonia. Diagnosis was established by clinical and radiological methods in 72 patients (78.3%), while invasive diagnostic methods, including bronchoscopy and mediastinoscopy were performed in 20 patients. It was observed that a definitive pathological diagnosis was reached in 22% of patients. Conclusion Diagnosis of ILD relies on the interpretation of history, clinical findings, imaging modalities, and biopsy results. Considering that the inability to perform invasive procedures in patients presenting with advanced respiratory failure complicates diagnosis, it is recommended that patients, especially those in tertiary care hospitals, be evaluated by multidisciplinary teams.
- 1 December 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (12) , 839-844
Retrospective evaluation of 92 cases on the diagnosis and treatment of interstitial lung diseases
Aim Interstitial lung diseases (ILDs) constitute a group of over 200 diseases affecting gas exchange, characterized by inflammation and fibroproliferation. The approach of a tertiary hospital to this heterogeneous group of diseases, which is challenging to manage, was reviewed to explore important features for diagnosis and treatment. Methods Ninety-two patients evaluated for ILD at the Department of Chest Diseases, Abant Izzet Baysal University Faculty of Medicine, between January 1, 2018, and 2019, were examined in terms of demographic characteristics, clinical findings, pulmonary function tests, radiological images, diagnostic methods, and treatment modalities. Results A total of 92 patients, with a mean age of 62.23 ± 11.78- years (range: 32-88), including 69 males, were evaluated. The most common presenting complaints among symptomatic patients (92.4%) were dyspnea (77.6%) and cough (64.7%). Following clinical, radiological, and pathological evaluations, various ILDs were identified, predominantly idiopathic pulmonary fibrosis (25%), followed by nonspecific interstitial pneumonia (15.2%), pneumoconiosis (15.2%), sarcoidosis, hypersensitivity pneumonitis, drug-induced lung diseases, collagen vascular diseases, Langerhans cell histiocytosis, respiratory bronchiolitis- associated ILD, lymphocytic interstitial pneumonia, and cryptogenic organizing pneumonia. Diagnosis was established by clinical and radiological methods in 72 patients (78.3%), while invasive diagnostic methods, including bronchoscopy and mediastinoscopy were performed in 20 patients. It was observed that a definitive pathological diagnosis was reached in 22% of patients. Conclusion Diagnosis of ILD relies on the interpretation of history, clinical findings, imaging modalities, and biopsy results. Considering that the inability to perform invasive procedures in patients presenting with advanced respiratory failure complicates diagnosis, it is recommended that patients, especially those in tertiary care hospitals, be evaluated by multidisciplinary teams.
- 1 November 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (11) , 799-802
Relationship between inflammatory parameters and total IgE values in patients diagnosed with asthma
Aim In this study, we aimed to investigate the relationship between Total IgE levels obtained during follow-up of asthma patients receiving moderate to high dose inhaled corticosteroid therapy with a pre-diagnosis of lower respiratory tract infection, and post-treatment, with infective parameters, hospitalization, and frequency of attacks. Methods Retrospective analysis was conducted on 132 patients diagnosed with asthma, despite the use of moderate to high dose inhaled steroids, based on their medical history, pulmonary function tests, and laboratory investigations. Results The frequency of Total IgE levels being 100 or higher in patients hospitalized in the last year and the frequency of decrease in Total IgE levels with a decrease in CRP levels were statistically significantly higher among the patients included in the study. In conclusion, the frequency of attacks and hospitalizations was statistically significant in patients with variable Total IgE levels. Conclusion We observed statistically significant increase in Total IgE levels in patients followed with a preliminary diagnosis of lower respiratory tract infection. Additionally, a significant correlation was observed between elevated Total IgE levels and patients who experienced exacerbations within a year and those hospitalized due to asthma attacks. This suggests that Total IgE may be valuable both in predicting the severity of the disease and in assessing the risk of exacerbation within a year in asthma patients. Furthermore, the data in our study suggest that serum Total IgE levels may be valuable as a biomarker in patients with Asthma-COPD overlap.
- 1 November 2024
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 15 (11) , 799-802
Relationship between inflammatory parameters and total IgE values in patients diagnosed with asthma
Aim In this study, we aimed to investigate the relationship between Total IgE levels obtained during follow-up of asthma patients receiving moderate to high dose inhaled corticosteroid therapy with a pre-diagnosis of lower respiratory tract infection, and post-treatment, with infective parameters, hospitalization, and frequency of attacks. Methods Retrospective analysis was conducted on 132 patients diagnosed with asthma, despite the use of moderate to high dose inhaled steroids, based on their medical history, pulmonary function tests, and laboratory investigations. Results The frequency of Total IgE levels being 100 or higher in patients hospitalized in the last year and the frequency of decrease in Total IgE levels with a decrease in CRP levels were statistically significantly higher among the patients included in the study. In conclusion, the frequency of attacks and hospitalizations was statistically significant in patients with variable Total IgE levels. Conclusion We observed statistically significant increase in Total IgE levels in patients followed with a preliminary diagnosis of lower respiratory tract infection. Additionally, a significant correlation was observed between elevated Total IgE levels and patients who experienced exacerbations within a year and those hospitalized due to asthma attacks. This suggests that Total IgE may be valuable both in predicting the severity of the disease and in assessing the risk of exacerbation within a year in asthma patients. Furthermore, the data in our study suggest that serum Total IgE levels may be valuable as a biomarker in patients with Asthma-COPD overlap.